Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of telaprevir in treatment-naive chronic hepatitis C genotype 4
2007-005281-12Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of telaprevir in chronic hepatitis C (CHC) (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Plasma hepatitis C virus RNA level. Started Oct 2007; status: completed.
02
Drugs
telaprevir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on 2007-005281-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005281-12.